World of DTC Marketing
MARCH 10, 2022
market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. billion last year, the highest total for any pharmaceutical product and they will do anything to keep that money. Sales of Humira earned AbbVie $20.7
pharmaphorum
JULY 27, 2022
Of all products approved by the European Medicines Association (EMA) between 2017 and 2020, 68% are currently available in England, a figure that stands at 54% in Scotland. In addition, the median time between regulatory approval and the first patient receiving a first dose was 247 days in 2020 – an increase of 25 days since 2018.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 19, 2022
Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 2020-02-24.
European Pharmaceutical Review
NOVEMBER 24, 2022
The European Union Intellectual Property Office/ Europol joint report confirms that counterfeit pharmaceuticals continue to be a big problem across the European Union zone and a substantial threat for most, if not all, member states. Counterfeit medicines and medical supplies can also cause significant harm to people, the report said.
European Pharmaceutical Review
NOVEMBER 3, 2022
It found in 2020, at the height of the pandemic, confidence dipped significantly, however scores have risen globally in the past two years. It is also very encouraging that… we see such optimism for pharmaceutical production next year,” commented Adam Andersen, Executive Vice President of Informa Markets.
Pharmaceutical Technology
MARCH 22, 2023
She continues: “Whether a vendor has a cloud-based registry, system, or database, it’s crucial that pharmaceutical companies who pre-tag for RFID systems use accepted, recognized global standards to encode drug data so products can be read by any system, just like the GS1 barcodes that are on every pharmaceutical product today.”
Pharmaceutical Technology
DECEMBER 20, 2022
In 2020, LianBio and Pfizer partnered to develop and commercialise transformative pharmaceutical products in Greater China. This deal excludes sisunatovir’s development and commercialisation rights in Mainland China, Singapore, Macau, and Hong Kong, which were previously licensed to LianBio in March last year.
Expert insights. Personalized for you.
205 
Let's personalize your content